Objective: Liver ischemia and reperfusion injury is a common source of significant morbidity and mortality following liver transplantation, hemorrhagic shock, or major hepatic surgery. Based on studies showing a critical role for the neuronal guidance receptor neogenin (Neo1) outside the nervous system in mediating tissue adaption during acute inflammation, we hypothesized that Neo1 enhances hepatic ischemia and reperfusion injury. Design: Animal study. Setting: University-based experimental laboratory. Subjects: Wid-type, neogenin deficient and chimeric mice. Interventions: Neogenin expression was evaluated during inflammatory stimulation in vitro and during ischemia and reperfusion injury in vivo, intravital microscopy performed to study intravascular flow characteristics. The extent of liver injury was evaluated using histology, serum levels of lactate dehydrogenase, aspartate, and alanine aminotransferase. The functional role of Neo1 during liver IR was evaluated in mice with gene targeted repression of neogenin (Neo1-/-), bone marrow chimeric animals and controls. In addition, functional inhibition of neogenin was performed using antibody injection. Measurements and Main Results: We observed an induction of Neo1 during inflammation in vitro and ischemia and reperfusion in vivo. Intravital microscopy demonstrated a decreased ability of Neo1 -/leukocytes to attach to endothelial vascular wall during inflammation. Subsequent studies in Neo1 -/mice showed attenuated serum levels of lactate dehydrogenase, aspartate, alanine, and proinflammatory cytokines during hepatic ischemia and reperfusion injury. This was associated with improved hepatic histology scores. Studies in chimeric animals demonstrated that the hematopoietic Neo1 expression to be crucial for the observed results. Treatment with an anti-Neo1 antibody resulted in a significant reduction of experimental hepatic ischemia and reperfusion injury, involving attenuated variable of lactate dehydrogenase, alanine, aspartate, and cytokine levels. Conclusions: These data provide a unique role for Neo1 in the development of hepatic ischemia and reperfusion injury and identified Neo1 as a potential target to prevent liver dysfunction in the future. (Crit Care Med 2014; 42:e610-e619) 
S everal clinical conditions such as tissue resection, transplantation surgery, or hemorrhagic shock are critical causes of liver dysfunction and hepatic failure (1) . Ischemia/reperfusion (IR) is the main source of liver damage during these events and contributes to significant morbidity and mortality (2) . Various underlying mechanisms of hepatic IR injury are known, including the induction of apoptosis and tissue necrosis, the generation of reactive oxygen species (3) , the release of proinflammatory cytokines, and the recruitment and activation of immunocompetent cells, such as neutrophils, Kupffer cells, and platelets (4) (5) (6) . Notably neutrophils play a key role in the emergence of hepatic IR injury (4, 5) . Accumulation of neutrophils in the liver significantly contributes to hepatocyte necrosis by release of proteolytic enzymes and superoxide anions during hepatic IR injury.
It is well established that the activation of leukocytes and the orchestration of an acute inflammatory response are controlled by the chemokine system (7) . However, recent studies provide evidence that neuronal guidance proteins (NGPs) and their target receptors display an alternative class of guidance cues in the immune system that steer immune responses particularly with regard to activation and migration of leukocytes (8, 9) . NGP was first identified in the developing CNS, where neurons and axons are precisely guided to their final location by a balance of chemoattractive and chemorepulsive signals to establish the elaborate neuronal circuitry (10, 11) . A crucial target receptor that mediates NGP signaling is the neogenin (Neo1) receptor (12, 13) . Previous studies have identified instructional roles for Neo1 and its ligands outside the nervous system during cell development, cell migration, and tissue inflammation (14) (15) (16) . Notably, Neo1 has been identified as a leukocyte-guidance cue expressed by the endothelium and epithelium that is induced during acute inflammation. Those studies established that neogenin influences the migration of neutrophils during acute peritonitis and acute pulmonary injury (14, 15) . Further studies of our group have identified that the repulsive guidance molecule (RGM)-A also holds significant impact on leukocyte migration during the acute phase of inflammation (8) . This work on RGM-A implicated that its anti-inflammatory potential is dependent on its target receptor Neo1 and indicated that Neo1 holds an intrinsic role during inflammatory events that is not well known to date.
Given the clinical significance of hepatic IR injury and the role of Neo1 for the control of an immune response, we sought to determine whether Neo1 contributed to liver IR injury (16) . Consistent with our hypothesis, we observed an induction of Neo1 during inflammation in vitro and in mice exposed to experimental hepatic IR injury in vivo. Furthermore, Neo1 -/mice presented with an attenuation of hepatic IR injury compared with littermate controls, showing reduced variables of lactate dehydrogenase (LDH), alanine, aspartate, polymorphonuclear leukocytes (PMN), proinflammatory cytokines, and improved histology scores. Studies in chimeric mice identified the myeloid expression of Neo1 to be critical for the detected results. Finally, we found that functional inhibition of Neo1 dampened the extent of hepatic injury following reperfusion. Taken together our data demonstrate, for the first time, a crucial role for Neo1 in experimental hepatic IR injury.
MethODs

Neo1 -/-Animals
Neogenin receptor knockout mice (Neo1 -/-) were kindly provided by Tessier-Lavigne (17) . All animal experiments were in accordance with the regulations of the Regierungspräsidium Tübingen. This study was reviewed by the local institutional review board and is exempt from requiring approval. Neo1 -/mice and controls were bred in parallel, and Neo1 -/animals did not display any evident pathological or physiological phenotype (regarding growth rate, mobility, and behavior), which was different from wild-type (WT) mice. Age of animals used was 8-10 weeks, and a mixed population (1:1 ratio male to female) was employed in all displayed experiments.
Generation of Chimeric Animals
To define the contribution of the myeloid and tissue-specific neogenin, we generated bone marrow chimeric mice in which bone marrow was ablated by radiation in WT mice (C57BL/6) followed by reconstitution with bone marrow derived from previously characterized mice gene-targeted for Neo1 -/and vice versa. To control for nonspecific radiation effects, bone marrow was transplanted from WT → WT and Neo1 -/-→ Neo1 -/mice. In short, male and female donor mice (8-10 wk old, 20-25 g) were euthanized, and the marrow from the tibia and femur was harvested by flushing the marrow cavity with sterile isotonic sodium chloride solution. The bone marrow cells were then centrifuged at 400 × g for 5 minutes, resuspended, and counted. Recipient mice (8-10 wk old, 20-25 g) were irradiated with a total dose of 12 Gy from a 137 Cs source. Immediately after irradiation, 10 7 bone marrow cells/recipient was injected intravenously. The resulting chimeric mice were housed in microisolators for at least 8 weeks before experimentation and fed with water containing tetracycline (100 mg/L) in the first 2 weeks following bone marrow transplantation. Success of transplantation was controlled by identifying switch of hematopoietic neogenin expression through real-time polymerase chain reaction (PCR) and Western blot analysis (Supplemental Fig. 1 , Supplemental Digital Content 1, http://links. lww.com/CCM/A982). After successful transplantation, mice were again exposed to the experimental protocol.
Murine Model of hepatic IR Injury
Following the induction of anesthesia, mice were placed on a heated table to maintain body temperature at 37°C. Midline laparotomy with caudal mobilization of the intestine was performed to display the liver and the portal triad. Partial liver ischemia was induced for 30 minutes by reversible occlusion of the portal triad using a hanging-weight system as described previously (18) . This was followed by a reperfusion phase of 3 hours before animals were euthanized and organs were harvested. Experiments were performed in n = 6-8 animals/group.
Quantification of Liver Injury
Serum alanine and aspartate aminotransferase levels were measured with a colorimetric kit (Teco Diagnostics, Anaheim, CA) as described previously (18) . LDH activity in the serum was measured using a photometric kit (Randox, Crumlin, United Kingdom).
Antibodies Used
Functional inhibition of Neo1 was achieved by IV injection of anti-Neo1 antibody (19) (1 μg in 150 μL; R&D Systems, Minneapolis, MN; AF 1079) 15 minutes prior to surgical procedures. Appropriate isotype immunoglobulin G was used as control.
Real-time PCR
To detect semiquantitative analysis of Neo1 messenger RNA (mRNA) in vitro, real-time PCR (iCycler; Bio-Rad Laboratories, Munich, Germany) was used. Primer sets contained 10 pM each of sense primer 5′-GGC AAT GGG GAA ATT CAG AA-3′ and the antisense primer 5′-TGA GGA GCA GCA CTG GGA A-3′. Samples were controlled for β-actin using following primers: sense 5′-GGT GGC TTT TAG GAT GGC AAG-3′, antisense 5′-ACT GGA ACG GTG AAG GTG ACA G-3′.
Murine transcriptional analysis of Neo1 mRNA levels was detected using sense primer 5′-GCT GCT CTC ACA GTC AAT GG-3 and 5-GCA TAA CCT CGG ACC ACA AT-3 antisense primer. Murine β-actin expression was evaluated with sense 5′-CTC TCC CTC ACG CCA TCC TG-3′ and antisense 5′-TCA CGC ACG ATT TCC CTC TCA G-3′.
Cytokine Measurement
Serum levels of interleukin (IL)-1β, keratinocyte-derived chemokine (KC), IL-6, and tumor necrosis factor (TNF)-α were measured using a multiplex bead immunoassay kit (Invitrogen, Darmstadt, Germany) in combination with a Luminex 100 system (Luminex, Austin, TX).
Cytology and Immunofluorescence
Freshly isolated 1 × 10 5 leukocytes were labeled using rabbit anti-Neogenin (Santa Cruz Biotechnology, Dallas, TX) and anti-CD15 (Abcam, Cambridge, UK) and visualized afterward. Flowcytometry was performed as described previously (20) . Fluorescence microscope LSM 510 Meta (Carl Zeiss, Jena, Germany) was used for imaging. BD FACS Canto II (BD Bioscience, San Jose, CA) employing BD FACS Diva Software was used for flowcytometry.
histologic Assessment and Determination of Myeloperoxidase
Immunohistochemical staining of PMN from paraffin-embedded tissue sections was done as described previously (21) . As primary antibody a rat anti-mouse Ly-6b.2 (AbD Serotec, Düsseldorf, Germany) and as secondary antibody a biotinylated rabbit anti-rat antibody (Vector Laboratories, Burlingame, CA) were used. Myeloperoxidase activity (MPO) was determined at 405nm in hepatic tissue using incubation of hepatic tissue with ABTS (Sigma-Aldrich, Munich, Germany) in the presence of hydrogen peroxide according to standard protocols. histology score Histologic sections were stained with hematoxylin and eosin (H&E). Examination and scoring (Suzuki scoring 0-4) based on the presence and/or severity of sinusoidal congestion, cytoplasmic vacuolization, and necrosis of parenchymal cells were applied (n = 4-6 for each condition) in a blinded fashion.
Lipopolysaccharide Inflammation and Intravital Microscopy
Neo1 -/animals and littermate controls were stimulated IV with lipopolysaccharide (30 μg/mouse) for 4 hours prior to intravital microscopy. All animals were anesthetized IP with a mixture of 0.05 mg/kg Fentanyl, 5 mg/kg Midazolam, and 0.5 mg/ kg medetomidine. Leukocyte-endothelium interactions in the cremaster microvasculature were analyzed as described previously (22) . Rolling leukocyte flux was defined as the number of cells moving slower than erythrocytes within a given vessel segment over 30 seconds. Leukocyte rolling velocity depicts the time required for leukocytes to roll over a venule length of 100 μm at any time within 30 seconds. Adherent leukocytes represent stationary cells on a venule for 15 seconds or longer.
Analysis of all leukocyte-endothelium interactions were performed on recorded playback videos and leukocyte emigration determined as the number of cells migrating to the extravascular space surrounding a framed postcapillary venule.
Data Analysis
All data are presented as mean ± sem. Statistical analysis was executed with GraphPad 5.0 software (GraphPad, San Diego, CA). For multiple comparisons one-way analysis of variance with Bonferroni adjustment was performed, and for single comparison, the unpaired Student t test was applied. The p values of less than 0.05 were considered significant.
ResULts expression Pattern of Neo1
We first addressed the question whether Neo1 is expressed in vivo on human PMN and if this expression would be altered during an inflammatory condition in vitro. For this, we isolated human PMN and stimulated these cells with TNF-α and performed transcriptional and translational expression analysis. Following this, we found a significant induction of Neo1 mRNA and protein expression in PMNs (Fig. 1, A-C) . We then aimed to assess whether this would also be present in vivo. For this, we employed WT animals and examined Neo1 expression after exposure to ischemia followed by reperfusion within murine tissue. We found a significant induction of Neo1 in WT animals following IR injury on a transcriptional and translational level (Fig. 1, D and E) .
To directly prove the hypothesis that Neo1 has influence on critical properties of leukocytes in vivo, we performed intravital microscopy in WT and Neo1 -/mice. Four hours after lipopolysaccharide injection, Neo1 -/mice demonstrated significantly lower number of adherent cells (Fig. 1F) , a higher rolling velocity (Fig. 1G) , and markedly reduced number of extravasated leukocytes (Fig. 1, H and I) .
hepatic IR Injury Is Reduced in Neo1-/-Mice After expressional analysis indicated that Neo1 was induced during IR injury, we next determined whether Neo1 holds functional impact on hepatic IR in vivo. For this, we used previously described Neo1 -/mice and littermate controls. Following hepatic IR, Neo1 -/mice displayed significant reduced serum levels of LDH, alanine, and aspartate compared with WT animals (Fig. 2, A-C) . Furthermore, we determined the extent of systemic inflammation through serum levels of cytokines. Levels of TNF-α, IL-1β, and IL-6 ( Fig. 2, D-F) were markedly reduced in Neo1 -/mice following hepatic IR. This was accompanied by a significant improved histologic score (Fig. 2, G and  H) , reduced infiltration of PMN, and decreased MPO activity within the affected liver tissue (Fig. 2, I-K) .
hematopoietic Neo1 Is of Key Importance for hepatic IR Injury
In the next step, we aimed to further identify the underlying mechanisms for the observed results. For this purpose, we generated chimeric animals (Neo1 -/-→ WT; WT → Neo1 -/-) to www.ccmjournal.org identify the contribution of hematopoietic or nonhematopoietic Neo1 to the extent of IR injury. Animals reconstituted with bone marrow from Neo1 -/animals showed significant reduced serum levels of LDH, alanine, aspartate, and inflammatory cytokines as compared with control animals following hepatic IR (Fig. 3, A-F) . This was associated with a significantly reduced infiltration of PMN and MPO activity within injured liver tissues (Fig. 3, G-I) . 
Functional Inhibition of Neo1 Is Protective During hepatic IR Injury
Finally, we tested the therapeutic potential of Neo1 inhibition in WT mice by injection of a functionally inhibiting anti-Neo1 antibody. Mice treated with this antibody showed significant reduced serum levels of LDH, alanine, and aspartate as compared with control animals following hepatic IR (Fig. 4,  A-C) . Additionally, serum levels of the cytokines TNF-α, IL-6, IL-1β, and KC were markedly decreased in the antibody treated group (Fig. 4, D-G) . This was associated with significantly attenuated infiltration of PMN and MPO activity in the affected liver tissue (Fig. 4, H-J) . 
DIsCUssION
Several studies have implicated that neuronal guidance molecules and their target receptors, initially characterized in the developing nervous system during axonal growth, modulate leukocyte migration during acute inflammation (9, 21, 23) . In the presented study, we have extended this concept and established that Neo1 is also an important propagator of neutrophil migration during reperfusion injury and as such aggravates hepatic inflammation during ischemia followed by reperfusion.
When searching for proteins involved into neurite extension, Vielmetter et al (24) initially described that neogenin is functionally involved into the transition from cell proliferation to terminal differentiation in specific cell types. Subsequent studies have then elucidated the functional role of Neo1 in the context of neuronal development. During axonal growth, Neo1 functions either chemoattractive or chemorepulsive for neuronal migration, depending on the agonist binding to it (12, 13) . Neogenin has been shown to act as a chemoattractive axon guidance receptor in the CNS upon netrin-1 binding (13) . In addition to this, Hata et al (25) demonstrated that the Unc5B receptor interacts with neogenin as a coreceptor for RGM-A to exert its function as a chemorepulsive protein during axonal development. A presence of neogenin outside the CNS was first demonstrated in the spleen, the intestine, the lung, and the thymus fairly soon after its initial description (26) . Fitzgerald et al (27) demonstrated robust expression of neogenin within embryonic lung tissue that was restricted to mesenchymal cells. Following embryonic development, descriptive data demonstrated that cerebral or renal ischemia reduces the expression of neogenin (28, 29) . This stands in contrast to the data we provide here; however, the above-mentioned studies did not investigate the functional implications of neogenin signaling in vitro or in vivo.
We report here that Neo1 is induced on a transcriptional and translational level during IR within the liver. Studies using in vivo microscopy revealed that Neo1 -/animals demonstrated reduced recruitment of inflammatory cells into the hepatic tissue, attenuated cytokine release and overall liver injury compared with controls. In these in vivo studies, we found that Neo1-deficient leukocytes presented reduced adhesion to endothelial cells that was associated with an increased flow velocity. This provides an explanation for the observed results of liver injury following reperfusion, since we found that the decreased liver injury was associated with reduced presence of neutrophils within the liver tissue of Neo1 -/animals. This finding was associated with the hematopoietic expression of Neo1, which confirms this observation. Additional pharmacologic studies with anti-Neo1 antibody treatment deciphered the protective potential of Neo1 inhibition. Tissue injury within the liver after the onset of reperfusion is the outcome of the interplay between different complex mechanisms, including endothelial cell swelling, vasoconstriction, leukocyte orchestration, and platelet aggregation within the sinusoids (30) . Recent studies have described the pro-or anti-inflammatory capacity of several axonal guidance proteins. These studies showed that members of the netrin, slit, semaphorin, ephrin, and RGM families of guidance molecules can have either chemoattractive and chemorepulsives effects on leukocyte trafficking. As a result, the extent of tissue inflammation can increase or decrease (9, 23, 31, 32) . Initial evidence that neogenin is involved into the control of an acute inflammatory response comes from one of our previous study, deciphering the role of RGM-A during acute inflammation (8) . In this study, we found that RGM-A reduces the chemotactic migration of neutrophils and that this effect is mediated through neogenin. RGM-A was able to mediate this anti-inflammatory effect in vitro and in vivo. Further evidence was provided during chronic inflammatory changes in the nervous system in which RGM-A activated T cells during multiple sclerosis. In the study by Muramatsu et al (33) , the authors define an activating role for RGM-A on T-cellmediated cytokine release within the CNS and demonstrated that RGM-A led to adhesion of T cells to intracellular adhesion molecule-1. We have subsequently described the endogenous role of neogenin during inflammatory peritonitis and acute lung injury. In both studies, we found a protective role for neogenin inhibition which reduced the extent of organ injury (14, 15) . We now also report that neogenin is important during IR injury and could be a potential target for the control of IR injury within hepatic tissue.
CONCLUsIONs
Taken together, the present studies provide a previously uncharacterized function for Neo1 during IR injury outside the nervous system. Our findings suggest that signaling through neogenin holds the capacity to increase the extent of IR injury. Therapeutic extensions of these findings suggest that a functional inhibition of Neo1 could represent a unique role for the treatment or prevention of ischemia and reperfusion injury through Neo1.
